alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IN THE DISTRICT COURT OF APPEAL OF THE STATE O F FLORIDA FIFTH DISTRICT NOT FINAL UNTIL TIME E XPIRES TO FILE MOTION FOR REHEARING AND DISPOSITION THEREOF IF FILED JAMES A. GEORGE, JR

. ,

Petitioner ,
v. Case No

. 5D 22

- 1 834 LT Case No. 2019

- CF

- 978
STATE OF FLORIDA,

Respondent. ________________________________/ Opinion filed October 7, 2022 Petition for Belated Appeal , A Case of Original Jurisdiction. James A. George, Jr., Raiford, pro se. Ashley Moody, Attorney General, Tallahassee, and Rebe cca Rock Mc Guigan , Assistant Attorney General, Daytona Beach, for Respondent.

PER CURIAM. T he petition f or belat ed appeal is granted. A copy of this opinion shall be filed with the tri al court and treate d as the notice of appeal from t he December 30 , 2019 judgment and sentence rendered in Case No

. 201 9-2

CF

- 978 , in the Circuit Court in and for Her nando County, Florida. See Fla. R. App. P. 9.141(c)( 6 )(D). PETITION GRANTED

. WALLIS , EISNAUGLE , and HARRIS , J J ., co ncur.
**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE**

**SARBANES-OXLEY ACT OF 2002**

I, Richard E. Gaetz, certify that: 

1. I havereviewed this Annual Report on Form 10-K of Vitran Corporation Inc.; 

2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding thereliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors: 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’s internal control over financial reporting. 

Date:February 9, 2011
1

Filed 10/23/20 P. v. Bennett CA3

NOT TO BE PUBLISHED

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for 

publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication 

or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

THIRD APPELLATE DISTRICT

(Butte)

----

THE PEOPLE,

Plaintiff and Respondent,

v.

CHRISTIAN DAVID BENNETT,

Defendant and Appellant.

C091136

(Super. Ct. No. 19CF03446)

Appointed counsel for defendant Christian David Bennett asked this court to 

review the record and determine whether there are any arguable issues on appeal. 

(People v. Wende (1979) 25 Cal.3d 436 (Wende).) Finding no arguable error that would 

result in a disposition more favorable to defendant, we will affirm the judgment.

I

Defendant was identified in a video showing him break into a car parked on the 

victim’s driveway and attempt to use a garage door opener in the car to open the victim’s 

garage. Defendant pleaded no contest to attempted residential burglary (Pen. Code, 

§§ 664/459)

1 in exchange for dismissal of a prior prison term enhancement allegation 

1 Undesignated statutory references are to the Penal Code.
2

(§ 667.5, subd. (b)), and the trial court denied defendant’s subsequent motion to withdraw 

the plea.

At a consolidated sentencing hearing, the trial court sentenced defendant to the 

upper term of three years for a second degree burglary conviction in a companion case

(case No. 18CF00660), and eight months (one-third the middle term) for the attempted 

burglary offense in this case. The trial court applied all presentence credits to case 

No. 18CF00660 and ordered defendant to pay various fines and fees. Defendant 

requested, but did not obtain, a certificate of probable cause.

II

Appointed counsel filed an opening brief setting forth the facts of the case and 

asking this court to review the record and determine whether there are any arguable 

issues on appeal. (Wende, supra, 25 Cal.3d 436.) Defendant was advised by counsel of 

the right to file a supplemental brief within 30 days of the date of filing the opening brief. 

More than 30 days elapsed and we received no communication from defendant.

Having undertaken an examination of the entire record, we find no arguable error 

that would result in a disposition more favorable to defendant.

DISPOSITION

The judgment is affirmed.

 /S/

MAURO, J.

We concur:

 /S/

ROBIE, Acting P. J.

 /S/

KRAUSE, J.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Pursuant to section 10(d) of the Federal Advisory Committee Act, as                           ( print page 9231)                        amended (5 U.S.C. App.), notice is hereby given of the following meeting.                

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Traumatic Brain Injury and Stroke Intervention.                    

*Date:*                         March 10-11, 2010.                    

*Time:*                         11 a.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting)                    

*Contact Person:*                         Kevin Walton, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-435-1785,                         *kevin.walton@nih.hhs.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: February 23, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-4178 Filed 2-26-10; 8:45 am]

BILLING CODE 4140-01-P
118TH CONGRESS 

2D SESSION H. R. 7593 

AN ACT 

To enhance the authority of the Director of the Congressional Research Service to obtain information directly 

from agencies of the Federal government. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 7593 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Modernizing the Con3 gressional Research Service’s Access to Data Act’’. 

4 SEC. 2. ACCESS OF CONGRESSIONAL RESEARCH SERVICE 

5 TO GOVERNMENT INFORMATION. 

6 (a) DIRECT ACCESS TO INFORMATION.—Section 203 

7 of the Legislative Reorganization Act of 1946 (2 U.S.C. 

8 166) is amended— 

9 (1) by redesignating subsection (j) as sub10 section (k); and 

11 (2) by inserting after subsection (i) the fol12 lowing new subsection: 

13 ‘‘(j)(1) In carrying out the duties and functions of 

14 the Congressional Research Service under subsection (d), 

15 the Director is authorized to secure books, records, cor16 respondence, memoranda, papers, documents, secure in17 formation, and other data in all forms directly from the 

18 various departments, agencies, and establishments of the 

19 executive branch of the Government and the regulatory 

20 agencies and commissions of the Government as the Direc21 tor determines to be necessary to carry out the request, 

22 and all such departments, agencies, establishments, and 

23 regulatory agencies and commissions shall furnish the Di24 rector with all such available material in a timely manner. 

25 ‘‘(2) With respect to books, records, correspondence, 

26 memoranda, papers, documents, secure information, and 
3 

•HR 7593 EH

1 other data in all forms obtained under paragraph (1), the 

2 Director shall maintain the same level of confidentiality 

3 as is required by law of the department, agency, establish4 ment, or regulatory agency or commission from which it 

5 is obtained. Officers and employees of the Congressional 

6 Research Service shall be subject to the same statutory 

7 penalties for unauthorized disclosure or use as officers or 

8 employees of the department, agency, establishment, or 

9 regulatory agency or commission from which it is ob10 tained.’’. 

11 (b) CONFORMING AMENDMENT.—Section 203(d)(1) 

12 of such Act (2 U.S.C. 166(d)(1)) is amended in the matter 

13 following subparagraph (C) by striking ‘‘and in the per14 formance of this duty’’ and all that follows through ‘‘com15 ply with such request;’’. 

Passed the House of Representatives September 9, 

2024. 

Attest: 

Clerk. 
118TH CONGRESS 

2D SESSION H. R. 7593 

AN ACT 

To enhance the authority of the Director of the 

ernment. mation directly from agencies of the Federal govCongressional Research Service to obtain infor-
EXHIBIT 21



SUBSIDIARIES OF THE REGISTRANT



Parent



The Southern Banc Company, Inc.



|Subsidiaries (1)          |  | State or Other Jurisdiction of Incorporation |  | Percentage Ownership
|------------------------- |  | -------------------------------------------- |  | --------------------
|The Southern Bank Company |  | United States                                |  | 100%                
|                          |  |                                             
|First Service Corporation |  | Alabama                                      |  | 100%                

---

|(1) |  | The assets, liabilities and operations of the subsidiaries are included in the consolidated financial statements attached hereto as an exhibit.
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------
#### § 700.23 Chlorofluorocarbon propellants.

The use of chlorofluorocarbons in cosmetics as propellants in self-pressurized containers is prohibited as provided in § 2.125 of this chapter.

[43 FR 11317, Mar. 17, 1978]
§ 573.600 Lignin sulfonates. Lignin sulfonates may be safely used in animal feeds in accordance with the following prescribed conditions: ( a ) For the purpose of this section, the food additive is either one, or a combination of, the ammonium, calcium, magnesium, or sodium salts of the extract of spent sulfite liquor derived from the sulfite digestion of wood or of abaca (*Musa textilis*) or of sisal (*Agave sisalana*) in either a liquid form (moisture not to exceed 50 percent by weight) or dry form (moisture not to exceed 6 percent by weight).
( b ) It is used or intended for use in an amount calculated on a dry weight basis, as follows: ( 1 ) As a pelleting aid in the liquid or dry form in an amount not to exceed 4 percent of the finished pellets.
( 2 ) As a binding aid in the liquid form in the flaking of feed grains in an amount not to exceed 4 percent of the flaked grain.
( 3 ) As a surfactant in molasses used in feeds, as liquid lignin sulfonate, in an amount not to exceed 11 percent of the molasses.
( 4 ) As a source of metabolizable energy, in the liquid or dry form, in an amount not to exceed 4 percent of the finished feed.
§ 50.1 Scope. ( a ) This part applies to all clinical investigations regulated by the Food and Drug Administration under sections 505(i) and 520(g) of the Federal Food, Drug, and Cosmetic Act, as well as clinical investigations that support applications for research or marketing permits for products regulated by the Food and Drug Administration, including foods, including dietary supplements, that bear a nutrient content claim or a health claim, infant formulas, food and color additives, drugs for human use, medical devices for human use, biological products for human use, and electronic products. Additional specific obligations and commitments of, and standards of conduct for, persons who sponsor or monitor clinical investigations involving particular test articles may also be found in other parts (e.g., parts 312 and 812). Compliance with these parts is intended to protect the rights and safety of subjects involved in investigations filed with the Food and Drug Administration pursuant to sections 403, 406, 409, 412, 413, 502, 503, 505, 510, 513-516, 518-520, 721, and 801 of the Federal Food, Drug, and Cosmetic Act and sections 351 and 354-360F of the Public Health Service Act.
( b ) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.
[45 FR 36390, May 30, 1980; 46 FR 8979, Jan. 27, 1981, as amended at 63 FR 26697, May 13, 1998; 64 FR 399, Jan. 5, 1999; 66 FR 20597, Apr. 24, 2001]
#### § 82.1602 D&C Violet No. 2.

The color additive D&C Violet No. 2 shall conform in identity and specifications to the requirements of § 74.1602(a)(1) and (b) of this chapter.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection  with the Quarterly  Report of CEC  Entertainment,  Inc. (the
"Company") on Form 10-Q for the quarter  ended  September 26, 2004 as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  the
undersigned  certifies,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.




                                            /s/ Richard M. Frank
                                            ------------------------------
                                            Richard M. Frank
                                            Chief Executive Officer
                                            November 4, 2004



A signed  original of this  written  statement  required by Section 906 has been
provided to CEC  Entertainment,  Inc. and will be retained by CEC Entertainment,
Inc. and furnished to the Securities  and Exchange  Commission or its staff upon
request.
p. 1 

# OAR Box 1796 Prepped by Keeia Richards



## Document

Number: 

# 23 ) IV-H-4 6 Docket Number: 

# A-90-3 7

Printed 10/31/2008 4:20:37PM

Sheet 23 of 107P. 2 Jef f Holmstea d 11/12/200 2 10:0 3 P M 

### A-90-3 7 To : jgraham@omb.eop.go vIV-H-4 6 cc : pnoe@omb.eop.gov , afraas@omb.eop.gov , B i Wehaim/DC/USEPMJS@EPA , Bil l Hamett/R i r/u3bPAAJS@EP A Subject : Interagenc

yRevie wo f NS R Rule s A s yo u know , w e normall yexpec t tha t interagenc yrevie wo f EP Arule s wil l tak e n o longe rtha n 9 0 days . However , becaus e o f th e numbe ro f comple xissue s presente d b yth e NS R rule s currentl yunde rreview , w e believ e tha t additiona l tim e beyon d th e norma l 90-da yperio d i s warranted . I woul d therefor e lik e t o reques t tha t th e interagenc yrevie wperio d fo rbot h NS R package s b e extende d unti l Decembe r1st .


# W 2 2 200 2 EP A AI R DOCKE

T
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from IDS Managed
Futures II, L.P. for the first quarter of 1997 and is qualified in its entirety
by reference to such 10-Q.
</LEGEND>
<CIK> 0000813831
<NAME> IDS MANAGED FUTURES II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1997
<CASH>                                      13,075,047
<SECURITIES>                                         0
<RECEIVABLES>                                   43,097
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            13,118,144
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              13,118,144
<CURRENT-LIABILITIES>                          408,904
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  12,709,240
<TOTAL-LIABILITY-AND-EQUITY>                13,118,144
<SALES>                                              0
<TOTAL-REVENUES>                               580,357
<CGS>                                                0
<TOTAL-COSTS>                                  218,023
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                362,334
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            362,334
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   362,334
<EPS-PRIMARY>                                    17.39
<EPS-DILUTED>                                    17.39
        

</TABLE>
§ 556.370 Lubabegron. ( a ) *Acceptable daily intake (ADI).* The ADI for total residues of lubabegron is 3 micrograms per kilogram of body weight per day.
( b ) *Tolerances.* The tolerances for lubabegron (marker residue) are: ( 1 ) *Cattle.* ( i ) Liver (target tissue): 10 ppb.
( ii ) Muscle: 3 ppb.
( iii ) Kidney: 20 ppb.
( 2 ) [Reserved]
( c ) *Related conditions of use.* See § 558.330 of this chapter.
[84 FR 12494, Apr. 2, 2019, as amended at 87 FR 17947, Mar. 29, 2022]
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, November 22, 2019.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, November 22, 2019

The Court of Appeals hereby passes the following order

A20A0263. LATASHA YVONNE WHITFIELD v. THE STATE.

Upon consideration of the APPELLANT'S motion FOR PERMISSION TO WITHDRAW 

THE APPEAL in the above styled case, it is ordered that the motion is hereby GRANTED.
# C_2015155EN.01004201.xml

| 11.5.2015 | EN | Official Journal of the European Union | C 155/42 |
| --- | --- | --- | --- |

11.5.2015

EN

Official Journal of the European Union

C 155/42

---

Judgment of the Civil Service Tribunal (First Chamber) of 26 March 2015 — CN v Parliament

(Case F-26/14) (1)

1

((Civil service - Accredited parliamentary assistants - Request for assistance - Psychological harassment))

(2015/C 155/61)

Language of the case: French

Parties

Parties

Applicant: CN (represented by: L. Levi, C. Bernard-Glanz and A. Tymen, lawyers)

Applicant:

Defendant: European Parliament (represented by: M. Ecker and S. Alves, Agents)

Defendant:

Re:

Re:

Application to annul the decision rejecting the request for assistance brought by the applicant for psychological harassment.

Operative part of the judgment

Operative part of the judgment

The Tribunal:

| 1) | Annuls the decision of the European Parliament implicitly rejecting CN’s request for assistance of 13 February 2013; |
| --- | --- |

1)

Annuls the decision of the European Parliament implicitly rejecting CN’s request for assistance of 13 February 2013;

| 2) | Annuls the decision of the European Parliament of 18 December 2013 dismissing CN’s complaint of 26 August 2013; |
| --- | --- |

2)

Annuls the decision of the European Parliament of 18 December 2013 dismissing CN’s complaint of 26 August 2013;

| 3) | Orders the European Parliament to pay CN the sum of EUR 45  785,29; |
| --- | --- |

3)

Orders the European Parliament to pay CN the sum of EUR 45  785,29;

| 4) | Orders the European Parliament to bear its own costs and to pay the costs incurred by CN. |
| --- | --- |

4)

Orders the European Parliament to bear its own costs and to pay the costs incurred by CN.

---

(1)  OJ C 175, 10/6/2014, p. 56.

1

---